Within the same tumor, areas with low tumor ASCL1 levels exhibited more CD8+ and CD4+ T cell infiltration, whereas areas with high tumor ASCL1 levels showed fewer CD8+ or CD4+ T cells (Fig. 4a). This evidence concerns the gene CD8A and neoplasm.